NASRIN GHESANI MD NPI 1023193000

NPI Details

Nasrin Ghesani, MD is a nuclear medicine in New York, NY with 34 years of experience. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone Nasrin Ghesani, MD NPI is 1023193000. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1 GUSTAVE L LEVY PL # 1141
NEW YORK, NY
ZIP 10029-504
Phone: (212) 241-6611

The NPI 1023193000 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Radioactive drug therapy through a vein (HCPCS:79101)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Nuclear medicine study, 1 area with spect and concurrent ct scan (HCPCS:78830)
• Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries (HCPCS:A9541)
• Nuclear medicine study, 1 area with spect and concurrent ct scan (HCPCS:78830)
• Radioactive drug therapy through a tube inserted in an artery (HCPCS:79445)
• Nuclear medicine study of lymphatic system (HCPCS:78195)
• Ct scan of chest with contrast (HCPCS:71260)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries (HCPCS:A9584)

The enumeration date for this NPI number is 10/26/2006 and was last updated on 6/16/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.